Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of …,

“Despite the fact that SGX942 demonstrated clinically meaningful reductions in oral mucositis consistent with the Phase 2 study, the Phase 3 trial did not …, “Despite the fact that SGX942 demonstrated clinically meaningful reductions in oral mucositis consistent with the Phase 2 study, the Phase 3 trial did not …, Read More

Scroll to Top